Showing results (281-290 of 1,581) with videos related to

Sort By:
Pageof 159
RSC Medicinal Chemistry|February 23, 2024
Glucosamine substituted sulfonylureas: IRS-PI3K-PKC-AKT-GLUT4 insulin signalling pathway intriguing agentGhadeer A R Y Suaifan, Bayan Alkhawaja, Mayadah B Shehadeh, et al.
RSC Medicinal Chemistry|February 23, 2024
Consensus screening for a challenging target: the quest for P-glycoprotein inhibitorsPaolo Governa, Marco Biagi, Fabrizio Manetti, et al.
RSC Medicinal Chemistry|February 23, 2024
Carbopol 940-based hydrogels loading synergistic combination of quercetin and luteolin from the herb Euphorbia humifusa to promote Staphylococcus aureus infected wound healingXiying Wu, Hao-Wei Chen, Ze-Yu Zhao, et al.
RSC Medicinal Chemistry|February 23, 2024
Overcoming barriers with non-covalent interactions: supramolecular recognition of adamantyl cucurbit[n]uril assemblies for medical applicationsMarija Alešković, Marina Šekutor
RSC Medicinal Chemistry|February 23, 2024
1-Benzylindoles as inhibitors of cytosolic phospholipase A2α: synthesis, biological activity, aqueous solubility, and cell permeabilityImke Meyer Zu Vilsendorf, Judith Einerhand, Dennis Mulac, et al.
RSC Medicinal Chemistry|May 24, 2024
PDE-stable 2'3'-cGAMP analogues, containing 5'-S-phosphorothioester linkage, as STING agonistsSimpa K Yeboah, Herman O Sintim
RSC Medicinal Chemistry|April 26, 2024
Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agentsKamalpreet Kaur, Harkomal Verma, Prabhakar Gangwar, et al.
RSC Medicinal Chemistry|April 26, 2024
AiZynth impact on medicinal chemistry practice at AstraZenecaJason D Shields, Rachel Howells, Gillian Lamont, et al.
RSC Medicinal Chemistry|April 26, 2024
Design, synthesis, and evaluation of novel ferrostatin derivatives for the prevention of HG-induced VEC ferroptosisXin-Xin Wang, Run-Jie Wang, Hua-Long Ji, et al.
RSC Medicinal Chemistry|April 26, 2024
In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancerLuísa Carvalho, Fábio Pedroso de Lima, Mónica Cerqueira, et al.
Pageof 159